Elisabeth Rocolle-Teyssier
Keine laufenden Positionen mehr
Profil
Elisabeth Rocolle-Teyssier worked as a Principal at Rhodia Chimie SAS and Alstom, Inc. She also served as the Chief Financial Officer at BioSystems International SAS.
Ehemalige bekannte Positionen von Elisabeth Rocolle-Teyssier
| Unternehmen | Position | Ende |
|---|---|---|
BioSystems International SAS
 BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Finanzdirektor/CFO | 06.03.2014 |
Alstom, Inc.
 Alstom, Inc. Financial ConglomeratesFinance Part of Alstom SA, Alstom, Inc. functions as an investment holding company. The company is based in Bethlehem, PA. | Corporate Officer/Principal | - |
Rhodia Chimie SAS
 Rhodia Chimie SAS Chemicals: SpecialtyProcess Industries Rhodia Chimie SAS produces specialty chemicals for food products. The company has partnerships with the automotive, electronic, health and other related sectors. The firm is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BioSystems International SAS
BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Health Technology |
Rhodia Chimie SAS
Rhodia Chimie SAS Chemicals: SpecialtyProcess Industries Rhodia Chimie SAS produces specialty chemicals for food products. The company has partnerships with the automotive, electronic, health and other related sectors. The firm is headquartered in Boulogne-Billancourt, France. | Process Industries |
Alstom, Inc.
Alstom, Inc. Financial ConglomeratesFinance Part of Alstom SA, Alstom, Inc. functions as an investment holding company. The company is based in Bethlehem, PA. | Finance |
